Optimind Pharma Stock

Optimind Pharma P/B

The P/B (Price-to-Book Ratio) of Optimind Pharma (OMND.CN) as of Aug 20, 2026 is -7.22. In the previous year, P/B (Price-to-Book Ratio) was -4.19 — a change of 72.46% (lower).

P/B

-7.22

YoY

72.46%

Last updated:

P/B (Price-to-Book Ratio) of Optimind Pharma is 2026 -7.22 . P/B (Price-to-Book Ratio) of Optimind Pharma was 2025 -4.19 . It decreases by 72.46% lower compared to the previous year.
Access this data via the Eulerpool API

Optimind Pharma Stock analysis

What does Optimind Pharma do? Optimind Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optimind Pharma stock

P/B (Price-to-Book Ratio) of Optimind Pharma is -7.22 in 2026.

P/B (Price-to-Book Ratio) of Optimind Pharma changed from -4.19 to -7.22, representing a 72.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Optimind Pharma since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Optimind Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Optimind Pharma

All Key Metrics — Optimind Pharma